chr22-25569513-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005160.4(GRK3):c.113+4360T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0128 in 152,308 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.013 ( 26 hom., cov: 33)
Consequence
GRK3
NM_005160.4 intron
NM_005160.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.270
Publications
1 publications found
Genes affected
GRK3 (HGNC:290): (G protein-coupled receptor kinase 3) The beta-adrenergic receptor kinase specifically phosphorylates the agonist-occupied form of the beta-adrenergic and related G protein-coupled receptors. Overall, the beta adrenergic receptor kinase 2 has 85% amino acid similarity with beta adrenergic receptor kinase 1, with the protein kinase catalytic domain having 95% similarity. These data suggest the existence of a family of receptor kinases which may serve broadly to regulate receptor function. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0537 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRK3 | NM_005160.4 | c.113+4360T>C | intron_variant | Intron 1 of 20 | ENST00000324198.11 | NP_005151.2 | ||
| GRK3 | NM_001362778.2 | c.-153+4360T>C | intron_variant | Intron 1 of 19 | NP_001349707.1 | |||
| GRK3 | XM_047441167.1 | c.113+4360T>C | intron_variant | Intron 1 of 13 | XP_047297123.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1946AN: 152190Hom.: 25 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1946
AN:
152190
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0128 AC: 1950AN: 152308Hom.: 26 Cov.: 33 AF XY: 0.0128 AC XY: 955AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
1950
AN:
152308
Hom.:
Cov.:
33
AF XY:
AC XY:
955
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
137
AN:
41574
American (AMR)
AF:
AC:
171
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
94
AN:
3470
East Asian (EAS)
AF:
AC:
16
AN:
5180
South Asian (SAS)
AF:
AC:
286
AN:
4820
European-Finnish (FIN)
AF:
AC:
99
AN:
10624
Middle Eastern (MID)
AF:
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1022
AN:
68020
Other (OTH)
AF:
AC:
31
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
93
187
280
374
467
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
98
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.